400 results
8-K
EX-99.1
ABT
Abbott Laboratories
17 Apr 24
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
7:36am
Research and development
Selling, general, and administrative
Total Operating Cost and Expenses
Operating Earnings
Interest expense, net
Net foreign
8-K
EX-99.1
ABT
Abbott Laboratories
24 Jan 24
Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial Outlook
7:36am
Net Sales
Cost of products sold, excluding amortization expense
Amortization of intangible assets
Research and development
Selling, general … amortization expense
Amortization of intangible assets
Research and development
Selling, general, and administrative
Total Operating Cost
8-K
EX-99.1
qga 6behyozck861mu50
18 Oct 23
Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
7:37am
8-K
EX-99.1
fp2tg1hl 8ap7ti78pr4
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
8-K
EX-99.1
om9p2kyx
19 Apr 23
Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
7:25am
8-K
EX-99.1
i34filj64a7z7o5mv0g
19 Oct 22
Abbott Reports Third-Quarter 2022 Results and Raises
7:58am
8-K
EX-99.1
4mx9k66zd 20ia
20 Jul 22
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
7:36am
8-K
EX-99.1
ffiail45m2
20 Apr 22
Abbott Reports First-Quarter 2022 Results
7:37am
8-K
EX-99.1
5k8ykz6eez7kiu 8asq
26 Jan 22
Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast
7:47am